Various Procedural Treatment Options for Androgenetic Alopecia

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexMale
Age20-50
SponsorSheikh Zayed Medical College

About this trial

Androgenetic alopecia (AGA)is the most common form of alopecia. It predominantly affects males, but there has been a significant surge in female preponderance too, over the last decade Minoxidil belong to the anti-hypertensive class but it also affects the potassium channels present in vascular smooth muscles and hair follicles. This potassium channel activity may stimulate the microcirculation around the hair follicles and induces arteriolar vasodilation, thereby encouraging conditions conducive to hair growth Topical administration of finasteride offers the potential to reduce systemic effects related to its mechanism of action by preferentially inhibiting 5-a reductase in the scalp, as has been suggested in recent years so in this study we are going to compare efficacy of topical minoxidil versus topical finasteride in treatment of androgenetic alopecia

Eligibility criteria

Qualifiers

Age: 20-50 years

Gender: Male

ANDROGENETIC ALOPECIA with AGA stage 2-6 Norwood-Hamilton -classification

Patients not taking any treatment in last 1 month

Disqualifiers

Abrasion or abnormalities to the scalp

Hair transplant

Hypersensitivity

Recent history of local infections of the head

Trial design

Treatments tested in this trial

  • topical finasteride
  • Topical minoxidil

Treatment groups

190 Participants
are divided into 2 treatment groups

Sponsors and collaborators